Skip to main content
. 2021 Nov 17;12:742834. doi: 10.3389/fimmu.2021.742834

Figure 2.

Figure 2

Percentage of CD4+ lymphocyte subpopulations of patients with 18q deletion syndrome, type 1 diabetes (DM), and healthy controls. (A) CD4+CD25+FOXP3+, (B) CD4+CD25+FOXP3+Helios+, (C) CD4+, (D) CD4+naïve, (E) CD4+T central memory, (F) CD4+T effective memory.